Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> WHO Provides New Medicines List, Policy Recommendations for Nuclear Emergency 27/01/2023 Maayan Hoffman The World Health Organization (WHO) on Friday released an updated list of medicines that should be stockpiled in the event of a radiological and nuclear emergency, along with new policy advice in the event of such an incident. “Preparedness for radiation emergencies is consistently reported as the weakest area of preparedness in many countries,” the […] Continue reading -> A Kickstart Towards Health Care ‘Ecosystems’ 20/01/2023 John Heilprin Across disciplines and sectors, experts say it will take treating health care as ‘ecosystems’ and a greater focus on access and equity to achieve solutions to critical health challenges of tomorrow and beyond. DAVOS, Switzerland – In the wake of the COVID-19 pandemic, huge inequities in access to health care have been exposed that demand […] Continue reading -> WHO Announces New TB Vaccine ‘Accelerator’ at Davos as High-Level Panel Discusses Elimination Challenge 18/01/2023 Megha Kaveri DAVOS, Switzerland – The World Health Organization (WHO) has announced plans to set up a new TB Vaccine Accelerator Council to increase momentum for the development of a vaccine to combat the world’s most deadly infectious disease. Speaking at a high-level panel at the World Economic Forum’s Annual Meeting where the plan was launched, WHO […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> US National Institutes of Health and Israel To Kick-off Joint Research Into Regional Emerging Disease Threats 05/01/2023 Maayan Hoffman In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Provides New Medicines List, Policy Recommendations for Nuclear Emergency 27/01/2023 Maayan Hoffman The World Health Organization (WHO) on Friday released an updated list of medicines that should be stockpiled in the event of a radiological and nuclear emergency, along with new policy advice in the event of such an incident. “Preparedness for radiation emergencies is consistently reported as the weakest area of preparedness in many countries,” the […] Continue reading -> A Kickstart Towards Health Care ‘Ecosystems’ 20/01/2023 John Heilprin Across disciplines and sectors, experts say it will take treating health care as ‘ecosystems’ and a greater focus on access and equity to achieve solutions to critical health challenges of tomorrow and beyond. DAVOS, Switzerland – In the wake of the COVID-19 pandemic, huge inequities in access to health care have been exposed that demand […] Continue reading -> WHO Announces New TB Vaccine ‘Accelerator’ at Davos as High-Level Panel Discusses Elimination Challenge 18/01/2023 Megha Kaveri DAVOS, Switzerland – The World Health Organization (WHO) has announced plans to set up a new TB Vaccine Accelerator Council to increase momentum for the development of a vaccine to combat the world’s most deadly infectious disease. Speaking at a high-level panel at the World Economic Forum’s Annual Meeting where the plan was launched, WHO […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> US National Institutes of Health and Israel To Kick-off Joint Research Into Regional Emerging Disease Threats 05/01/2023 Maayan Hoffman In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A Kickstart Towards Health Care ‘Ecosystems’ 20/01/2023 John Heilprin Across disciplines and sectors, experts say it will take treating health care as ‘ecosystems’ and a greater focus on access and equity to achieve solutions to critical health challenges of tomorrow and beyond. DAVOS, Switzerland – In the wake of the COVID-19 pandemic, huge inequities in access to health care have been exposed that demand […] Continue reading -> WHO Announces New TB Vaccine ‘Accelerator’ at Davos as High-Level Panel Discusses Elimination Challenge 18/01/2023 Megha Kaveri DAVOS, Switzerland – The World Health Organization (WHO) has announced plans to set up a new TB Vaccine Accelerator Council to increase momentum for the development of a vaccine to combat the world’s most deadly infectious disease. Speaking at a high-level panel at the World Economic Forum’s Annual Meeting where the plan was launched, WHO […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> US National Institutes of Health and Israel To Kick-off Joint Research Into Regional Emerging Disease Threats 05/01/2023 Maayan Hoffman In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Announces New TB Vaccine ‘Accelerator’ at Davos as High-Level Panel Discusses Elimination Challenge 18/01/2023 Megha Kaveri DAVOS, Switzerland – The World Health Organization (WHO) has announced plans to set up a new TB Vaccine Accelerator Council to increase momentum for the development of a vaccine to combat the world’s most deadly infectious disease. Speaking at a high-level panel at the World Economic Forum’s Annual Meeting where the plan was launched, WHO […] Continue reading -> Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> US National Institutes of Health and Israel To Kick-off Joint Research Into Regional Emerging Disease Threats 05/01/2023 Maayan Hoffman In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Novel Ways to Advance Sudan Ebolavirus Vaccine Candidates? Experts Meet as Uganda’s Outbreak Declared Over 11/01/2023 Elaine Ruth Fletcher WHO’s Africa Region has declared the end to the recent outbreak of Sudan Ebolavirus – just a day before WHO convenes Ebola experts in a global consultation to explore a way forward on testing three candidate vaccines for the deadly Sudan strain of the virus. The oubreak was declared over after the elapse of 44 […] Continue reading -> US National Institutes of Health and Israel To Kick-off Joint Research Into Regional Emerging Disease Threats 05/01/2023 Maayan Hoffman In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US National Institutes of Health and Israel To Kick-off Joint Research Into Regional Emerging Disease Threats 05/01/2023 Maayan Hoffman In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> Posts navigation Older postsNewer posts